Phio Pharmaceuticals Corp (PHIO)
US$ 1.72-8.51%
Price Chart
Key Statistics
Market Cap
$ 9.37M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
237.17K
52W High
$ 9.79
52W Low
$ 0.97
Dividend Yield
0.00%
Beta
1.08
Technicals
50-Day MA
1.6011
200-Day MA
2.4889
52 Week High
9.79
52 Week Low
0.9657
About PHIO
Phio Pharmaceuticals Corp., a a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.
Employees
5
Headquarters
Marlborough, MA
CEO
Mr. Robert J. Bitterman
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg